Randomized Trial: 7-day Primaquine As Good as 14-day Primaquine for the Radical Cure of Plasmodium Vivax Malaria

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial – The Lancet (free)

Commentary: A shorter course for anti-relapse therapy against vivax malaria – The Lancet (free)

Related Commentary on Twitter

NEW Research—In patients with normal G6PD, 7-day primaquine was well tolerated and non-inferior to 14-day primaquine for the radical cure of P vivax #malaria: finding from a multicentre, randomised, placebo-controlled non-inferiority trial https://t.co/uAtXqpGTXA pic.twitter.com/sFSSCtvQBT

— The Lancet (@TheLancet) July 18, 2019